Context Capital Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Context Capital Management’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,569	Closed	-$3K	–	361
2023 Q1	$3K	Hold	66,569	–	–	﹤0.01%	323
2022 Q4	$1K	Hold	66,569	–	–	﹤0.01%	435
2022 Q3	$6K	Sell	66,569 -1,100	-2%	-$119	﹤0.01%	502
2022 Q2	$9K	Hold	67,669	–	–	﹤0.01%	527
2022 Q1	$19K	Buy	+67,669	New	+$24.7K	﹤0.01%	585

Context Capital Management's IQMDW Position: Q2 2023 in Review

Context Capital Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 66,569 shares — an estimated $3K sold.

Context Capital Management first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $19K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Context Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Context Capital Management sold 66,569 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $3K.
Context Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
Context Capital Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $19K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Context Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.